Angle (AGL)

 

Latest News

Selected for European Cancer ID Programme

RNS Number: 6697W Angle PLC 13 February 2017 For immediate release 13 February 2017 ANGLE plc ("the Company") PARSORTIX SELECTED FOR EUROPEAN CANCER-ID PROGRAMME ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, is pleased to announce that it has been formally selected for CANCER-ID, the European con...

Interim Evaluation of Ovarian Cancer Study

RNS Number: 1486V Angle PLC 26 January 2017 For immediate release 26 January 2017 ANGLE plc ("the Company") POSITIVE INTERIM EVALUATION OF OVARIAN CANCER CLINICAL STUDIES Patient enrolment European study now over 90% complete and US study 70% complete Headline data from the full studies expected in Q2, 2017 ANGLE plc (A...

Interim Results

RNS Number: 1504V Angle PLC 26 January 2017 For Immediate Release 26 January 2017 ANGLE plc ("ANGLE" or "the Company") Interim Results for the six months ended 31 October 2016 OVARIAN CANCER CLINICAL STUDIES PROGRESSING WELL ANGLE plc (AIM: AGL and OTCQX: ANPCY), the specialist medtech company, today announces its unau...

ANGLE Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017

Andrew Newland the Chief Executive of ANGLE Plc (AGL) [LSE:AGL] the specialist medtech company, is to present at th...

All News

DateHeadlineSource
13-02-17Selected for European Cancer ID ProgrammeRNS
26-01-17Interim Evaluation of Ovarian Cancer StudyRNS
26-01-17Interim ResultsRNS
06-01-17ANGLE Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017StockMarketWire
04-01-17ANGLE schedules interims StockMarketWire
04-01-17Notice of ResultsRNS
29-12-16Our AIM tip soars 60% in 2016 Interactive Investor
28-11-16ISSUE OF SHARE OPTIONSRNS
24-11-16Result of GMRNS
04-11-16ANGLE welcomes new research supporting Parsortix StockMarketWire
04-11-16Barts Research Supports Potential Use of ParsortixRNS
01-11-16Notice of GMRNS
27-10-16Director's share purchaseRNS
07-10-16Holding(s) in CompanyRNS
04-10-16Result of AGMRNS
30-09-16ANGLE notes research results in Clinical ChemistryStockMarketWire
30-09-16Research published in Clinical ChemistryRNS
19-09-16Issue of EquityRNS
09-09-16Annual Report and Accounts and Notice of AGMRNS
04-08-16MD Anderson Cancer Center poster presentationRNS
02-08-16Edison issues ADR update on AngleRNS
28-07-16ANGLE revenue upStockMarketWire
28-07-16Use of Parsortix in GANNET53 drug trialRNS
28-07-16Preliminary ResultsRNS
27-07-16ANGLE initiates ovarian cancer study in the USStockMarketWire
27-07-16Initiation of 200 patient US ovarian cancer studyRNS
19-07-16ANGLE initiates European ovarian cancer study StockMarketWire
19-07-16Initiation of European ovarian cancer studyRNS
15-07-16Notice of ResultsRNS
15-07-16Parsortix gaining traction at EACR ConferenceRNS
01-06-16Holding(s) in CompanyRNS
31-05-16Holding(s) in CompanyRNS
27-05-16Edison research update on AngleStockMarketWire
27-05-16Edison issues research update on AngleRNS
25-05-16ANGLE wins contract with Cancer Research UKStockMarketWire
25-05-16PlacingRNS
25-05-16Cancer Research UK ContractRNS
29-04-16NEW PUBLICATIONS UTILISING PARSORTIXRNS
22-04-16AIM share tips 2016: the first four monthsInteractive Investor
19-04-16Edison research update on AngleStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory